… per population (e.g., PD, dementia with Lewy bodies, multiple system atrophy) Selective in vivo binding to alpha-synuclein …

… company has created a quantitative, objective measurement system for multiple sclerosis (MS), and with the help of this grant, … complete picture of PD.   “Building on Octave’s progress in multiple sclerosis, we are thrilled to work with MJFF to …

… afford an opportunity to study an immunologically protected system such as the brain. Over the past 16 years, she has … monocyte-derived macrophages as disease promoters in Multiple Sclerosis and 3) identified distinct blood-forming … neurodegenerative disease models. Currently, she is using a system immunological approach to explore the nature of …

… cristae membranes tight, deficient in dominant optic atrophy and targeted during apoptosis; (ii) identified the …

… neurological disorders, such as myasthenia gravis and multiple sclerosis. She was awarded with a Career … interest is to explore the interaction between the nervous system and immune system influencing the development and pathogenesis of …

… Grant: NeuroPhage technology simultaneously targets multiple misfolded proteins (e.g., alpha-synuclein, … to the early lead candidate, NPT001. NPT088 can be dosed systemically, which provides a significant advantage over … project, a single, dose-level study of NPT088 followed by a multiple dose-level study will be conducted in …